Stocks · Health care · Pharmaceutical Preparations

ROCKET PHARMACEUTICALS, INC.

RCKT Clue Score36
United States Fiscal year ends December CIK 0001281895 Results filed 10 Aug 2026

What the insiders did Balanced

By person

24 insiders · 142 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rtw Investments, LP entity
Director
$48.50M (4)
$29.02M (1)
+$19.48M
49,833,695
45.40%
$169.58M
+1.7%
Gotham Makker
Director
—
$10.20M (6)
−$10.20M
1,711,747
1.56%
$5.83M
−34.9%
David P Southwell
Director
$105.00K (1)
$3.41M (6) scheduled
−$3.30M
317,646
0.2894%
$1.08M
+145.3%
Gaurav Shah
CEO
$483.11K (2)
$3.33M (21)
−$2.85M
1,462,832
1.33%
$4.98M
+65.0%
Kinnari Patel
See Remarks
$193.68K (3)
$1.52M (11)
−$1.33M
665,240
0.6060%
$2.26M
+129.4%
Jonathan David Schwartz
See Remarks
—
$1.09M (13)
−$1.09M
299,064
0.2724%
$1.02M
—
John Militello
See Remarks
—
$906.52K (33)
−$906.52K
89,780
0.0818%
$305.52K
+1,970%
Martin Wilson
General Counsel
—
$705.82K (19)
−$705.82K
598,489
0.5452%
$2.04M
+2,981%
Mark Andrew White
See Remarks
—
$421.68K (3)
−$421.68K
69,140
0.0630%
$235.28K
+345,600%
Christopher James Stevens
Chief Operating Officer
—
$128.27K (1)
−$128.27K
505,784
0.4607%
$1.72M
—
Sarbani Chaudhuri
See Remarks
—
$84.19K (2)
−$84.19K
262,809
0.2394%
$894.34K
+65.0%
Elisabeth Bjork
Director
$68.50K (2)
—
+$68.50K
50,000
0.0455%
$170.15K
—
Aaron Ondrey
Chief Financial Officer
—
$43.90K (2)
−$43.90K
128,173
0.1168%
$436.17K
—
Naveen Yalamanchi
Director
—
$14.01K (1)
−$14.01K
113,641
0.1035%
$386.72K
−0.6%
Roderick Wong
Director
—
—
—
32,855,453
29.93%
$111.81M
+6.3%
Syed Ali-aamir Rizvi
Chief Medical Officer
—
—
—
407,874
0.3716%
$1.39M
—
Peter Fong
Director
—
—
—
76,195
0.0694%
$259.29K
—
Mikael Dolsten
Director
—
—
—
67,082
0.0611%
$228.28K
—
Pedro P Granadillo
Director
—
—
—
54,734
0.0499%
$186.26K
—
Fady Ibraham Malik
Director
—
—
—
52,862
0.0482%
$179.89K
—
Carsten Boess
Director
—
—
—
52,862
0.0482%
$179.89K
—
Piratip Pratumsuwan
Director
—
—
—
30,000
0.0273%
$102.09K
—
Dale Ritter
Vice President, Finance
—
—
—
19,827
0.0181%
$67.47K
+170.6%
Devon Park Bioventures LP entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%